Skip to main content
. 2012 Jan 20;2(1):e53. doi: 10.1038/bcj.2011.51

Figure 3.

Figure 3

Plasma miR-92a expression in MM at various clinical phases and SMM or MGUS. (a) The downregulated plasma miR-92a level at myeloma diagnosis (MM-Dx) was normalized in CR (MM-CR) and was partially normalized at VGPR (MM-VGPR) or PR (MM-PR) phase. (b) Patients with SMM had a higher plasma miR-92a level than that of symptomatic myeloma (P=0.0496), but they had low levels compared with normal subjects. Although some patients with MGUS had low levels of plasma miR-92a, most MGUS patients had plasma miR-92a levels similar to those with SMM. Bars indicate minimum to maximum plasma miR-92a levels and boxes indicate 95% CI.